The US Food and Drug Administration (FDA) is cautioning patients and caregivers about the potential for not receiving blood ...

Several executive orders recently signed by US President Donald Trump may have significant implications for the US Food and Drug Administration ...

Tazbaz was director of the FDA’s Digital Health Center of Excellence for two years, leading key policies on artificial intelligence and software as a medical device.

The Cybersecurity and Infrastructure Security Agency and Food and Drug Administration Jan. 30 released notices warning of ...

The FDA’s framework for AI regulation, while robust for premarket evaluation, would benefit from more specific mechanisms for continuous monitoring of AI performance in diverse real-world settings.

Tazbaz was director of the FDA’s Digital Health Center of Excellence for two years, leading on policies involving artificial ...

Beta CEO Marcel Botha talks about the FDA’s plans for medical shortage notifications and how Trump’s policies may impact US ...

MDR Certification Strengthens Resyca's Leadership in Soft Mist Drug-Device Combination Products ENSCHEDE, NL / ACCESS Newswire / January 28, 2025 / Resyca BV, a pioneering leader in the development an ...

In the United States, the biomedical industry encounters numerous regulatory challenges in conducting nonclinical and ...

This rising trend mirrors the evolution of the pharmaceutical industry in terms of investment and utilisation of novel ...

Our primary statutory objective is to protect public health and consumers' other interests in relation to food. Excessive or unclear regulation places an unnecessary burden on business and hinder ...